(Q35110883)

6 August 2017

1 reference

title

Primum non nocere: Should adults with idiopathic FSGS receive steroids? (English)

1 reference

6 August 2017

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

25 December 2023

author name string

Nora Franceschini

1

1 reference

6 August 2017

Susan Lynn Hogan

2

1 reference

6 August 2017

Ronald J. Falk

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12704583

25 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12704583

25 December 2023

publication date

1 March 2003

1 reference

full work available at URL

6 August 2017

http://www.seminarsinnephrology.org/article/S0270929503700254/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12704583

https://api.elsevier.com/content/article/PII:S0270929503700254?httpAccept=text/xml

25 December 2023

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

https://api.elsevier.com/content/article/PII:S0270929503700254?httpAccept=text/plain

25 December 2023

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

25 December 2023

published in

Seminars in Nephrology

1 reference

6 August 2017

volume

23

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

229-233

1 reference

Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study

6 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Management of complications of glucocorticoid therapy

25 December 2023

2

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events

25 December 2023

3

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Incidence of arteriosclerosis in patients with rheumatoid arthritis receiving long-term corticosteroid therapy

25 December 2023

4

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Primary focal segmental glomerulosclerosis: clinical course and response to therapy

25 December 2023

5

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Management of focal segmental glomerulosclerosis: evidence-based recommendations.

25 December 2023

6

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment

25 December 2023

7

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Idiopathic adult focal segmental glomerulosclerosis: a clinicopathological study and response to steroid

25 December 2023

8

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Long-term outcome in children and adults with classic focal segmental glomerulosclerosis

25 December 2023

9

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?

25 December 2023

10

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Treatment of primary focal segmental glomerulosclerosis

25 December 2023

12

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

The glomerular tip lesion: a previously undescribed type of segmental glomerular abnormality

25 December 2023

13

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Further studies on the glomerular tip lesion: early and late stages and life table analysis

25 December 2023

14

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis

25 December 2023

17

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study

25 December 2023

18

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Collapsing glomerulopathy: clinical characteristics and follow-up

25 December 2023

19

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Primary focal segmental glomerular sclerosis in adults: prognostic value of histologic variants

25 December 2023

20

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children

25 December 2023

24

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies

25 December 2023

25

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

25 December 2023

26

1 reference

https://api.crossref.org/works/10.1053/SNEP.2003.50021

25 December 2023

Identifiers

1 reference

6 August 2017

1 reference